Orion: Annual Summary of Stock Exchange Releases and Announcements published in 2007
7 February 2008 at 9.35 a.m.
|
24.01.2007 |
Change in the Executive Management Board of the Orion Group as of 1 February 2007 |
|
24.01.2007 |
Share-based incentive plan for ca. 30 key persons in Orion |
|
29.01.2007 |
Recommendation by the Nomination Committee concerning Board of Directors to be elected by the AGM of Orion Corporation |
|
06.02.2007 |
Bulletin of Orion Corporation Financial Statements for 1 July - 31 December 2006 |
|
06.02.2007 |
Orion Group Financial Review (proforma) 1-12/2006 |
|
06.02.2007 |
Orion updates progress with Simdax (i.v. levosimendan): |
|
06.02.2007 |
Matters to be handled at Orion's AGM on 2 April 2007 |
|
01.03.2007 |
Orion Group Annual Report 2006 published |
|
08.03.2007 |
Amendment to the Annual Report 2006 of Orion Corporation concerning holdings of Board members |
|
02.04.2007 |
Decisions by the AGM of Orion Corporation on 2 April 2007 |
|
02.04.2007 |
Jukka Ylppö Vice Chairman of the Board of Directors of Orion Corporation. Compositions of Board committees |
|
25.04.2007 |
Orion's partner discontinues development of levosimendan (Simdax) in the US |
|
25.04.2007 |
Orion Group Interim Report 1-3/2007 |
|
06.08.2007 |
Orion Group Interim Report 1-6/2007 |
|
06.08.2007 |
Decision of the Board of Directors of Orion on repurchasing own shares |
|
13.08.2007 |
Orion comments on ANDA filing of generic entacapone (Orion's proprietary drug Comtan®) in the United States |
|
11.09.2007 |
New President and CEO for Orion Corporation as of 1 January 2008 |
|
13.09.2007 |
Orion sues generic drug companies in the U.S. to enforce patents for entacapone (Orion's proprietary drug Comtan®) |
|
01.10.2007 |
Orion comments on ANDA filing of generic versions of Orion's proprietary drug Stalevo® in the United States |
|
24.10.2007 |
Orion Group Interim Report 1-9/2007 |
|
24.10.2007 |
Orion Corporation's publication schedules for financial reporting in 2008 |
|
24.10.2007 |
Composition of the Nomination Committee of Orion Corporation |
|
13.11.2007 |
Orion sues Sun Pharmaceuticals in the U.S. to enforce a patent for Stalevo® |
|
15.11.2007 |
Appointments into Orion's Executive Management Board as of 1 January 2008 |
|
27.11.2007 |
Announcement by Orion Corporation in accordance with section 10 of chapter 2 of the Finnish Securities Market Act |
|
18.01.2007 |
223,000 Orion A-shares converted into B-shares |
|
26.01.2007 |
70,000 Orion A-shares converted into B-shares |
|
19.04.2007 |
Changes in Orion's Articles of Association entered in the Trade Register on 19 April 2007 |
|
26.04.2007 |
905,839 Orion A-shares converted into B-shares |
|
21.05.2007 |
532,051 Orion A-shares converted into B-shares |
|
21.06.2007 |
335,315 Orion A-shares converted into B-shares |
|
06.07.2007 |
100,000 Orion A-shares converted into B-shares |
|
31.08.2007 |
398,000 Orion A-shares converted into B-shares |
|
07.11.2007 |
171,347 Orion A-shares converted into B-shares |
|
17.12.2007 |
260,000 Orion A-shares converted into B-shares |
